On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Save 20% on Press Releases and More with NNW Prime! Click to View Details

Earth Science Tech, Inc. (ETST) Enlarges Its Footprint in Hemp-Based CBD Market

Agreement with Mr. Checkout will significantly strengthen the company’s product distribution network Human trials launched evaluating CBD-based therapy for opioid addiction Application made to uplist to OTCQB in early 2018, attracting more investment The worldwide cannabidiol (CBD) oil market, which includes products derived from both marijuana and hemp, is projected to grow at a CAGR … Continue reading “Earth Science Tech, Inc. (ETST) Enlarges Its Footprint in Hemp-Based CBD Market”

NetworkNewsBreaks – Earth Science Tech, Inc. (ETST) Subsidiary Receives Grant from the Government of Québec

In a news release this morning, Earth Science Tech (OTC: ETST) announced that its subsidiary, Canna Inno Laboratories Inc., has been awarded a supporting grant by the Ministère de l’économie, des sciences et de l’innovation of the Government of Québec for innovation in the pharmaceutical industry. The grant has been set aside for its three … Continue reading “NetworkNewsBreaks – Earth Science Tech, Inc. (ETST) Subsidiary Receives Grant from the Government of Québec”

NetworkNewsAudio – Earth Science Tech, Inc. (ETST) Finalizes Plans for Human Trials on New CBD-Based Formula Targeting Opioid Addiction Epidemic

Related Press Release Earth Science Tech, Inc. (OTC: ETST), an innovative biotech company focused on the cannabinoid (“CBD”), nutraceutical and pharmaceutical fields, as well as on R&D for certain medical devices, today announces that it has finalized the plans for its previously announced human trial to assess the efficacy of the combination of an essential … Continue reading “NetworkNewsAudio – Earth Science Tech, Inc. (ETST) Finalizes Plans for Human Trials on New CBD-Based Formula Targeting Opioid Addiction Epidemic”

Earth Science Tech, Inc. (ETST) Scientifically Advancing CBD

Company committed to scientific validation of CBD efficacy Produces, markets and sells only the highest quality Full-Spectrum Hemp Oil containing CBD With new subsidiaries and acquisition, future is increasingly bright Building on vast anecdotal and mounting scientific evidence, the market for cannabidiol (CBD) products is exploding across the globe. The discovery of the human endocannabinoid … Continue reading “Earth Science Tech, Inc. (ETST) Scientifically Advancing CBD”

NetworkNewsBreaks – Earth Science Tech, Inc. (ETST) Finalizes Plans for Human Trial of CBD-based Formula Targeting Opioid Addiction

Earth Science Tech, Inc. (OTC: ETST) this morning reported that it has finalized preparations for its nine-month human trial to evaluate the effectiveness of a blend of broad-spectrum cannabinoid industrial hemp oil and essential mineral element. The trial seeks to develop a CBD formulation for the treatment of opioid addicts, relieving withdrawal symptoms, and averting … Continue reading “NetworkNewsBreaks – Earth Science Tech, Inc. (ETST) Finalizes Plans for Human Trial of CBD-based Formula Targeting Opioid Addiction”

NetworkNewsBreaks – Earth Science Tech, Inc. (ETST) Focuses on Completing Key Projects in 2018

Science-based biotechnology company Earth Science Tech, Inc. (OTC: ETST) has set its sights on a momentous year in 2018 with many noteworthy tasks on the horizon. An article discussing the company reads: “Earth Science Tech, Inc. (OTC: ETST) is working toward an uplisting to the OTCQB Venture Market in early 2018. It has also retained … Continue reading “NetworkNewsBreaks – Earth Science Tech, Inc. (ETST) Focuses on Completing Key Projects in 2018”

Earth Science Tech, Inc.’s (ETST) European Industrial Hemp and Mr. Checkout Could be Key Players in 2018

ETST projects a breakout year in 2018 from its new line of High Grade Full Spectrum Cannabinoids, marketed as a cannabinoid complex Checkout sells to major retailers, such as Walmart and Target, as well as a network of independent distributors and retail owners ETST’s new line is sourced from European industrial hemp, but it is … Continue reading “Earth Science Tech, Inc.’s (ETST) European Industrial Hemp and Mr. Checkout Could be Key Players in 2018”

NetworkNewsBreaks – Earth Science Tech, Inc. (ETST) Advances in Prosperous Cannabis Industry

Science-based biotechnology company Earth Science Tech, Inc. (OTC: ETST) is optimistic about its ability to serve the medical and recreational needs of a growing population of cannabis users. An article discussing the company reads: “Earth Science Tech, Inc. announced in May 2014 that it was entering the legal cannabis and medical marijuana industry as a … Continue reading “NetworkNewsBreaks – Earth Science Tech, Inc. (ETST) Advances in Prosperous Cannabis Industry”

Earth Science Tech, Inc. (ETST) Launches High Grade Full Spectrum Cannabinoid Products

ETST intends to make 2018 its breakout year, seeks uplisting to the OTCQB Venture Market Company manufactures using European CO2 extraction process with organically grown, unfiltered industrial hemp ETST engages a new distributor to market revamped product line to major retailers, also adds several new members to its executive team On February 13, Earth Science … Continue reading “Earth Science Tech, Inc. (ETST) Launches High Grade Full Spectrum Cannabinoid Products”

NetworkNewsBreaks – Earth Science Tech, Inc. (ETST) Secures Laboratory Partner for Clinical Studies of MSN-2 Medical Device

Science-based biotechnology company Earth Science Tech, Inc. (OTC: ETST) recently signed an agreement with a private laboratory for clinical studies related to its MSN-2 medical device. “We are on the cusp of making tremendous progress in our clinical trial efforts,” Dr. Michel Aubé, CEO and CSO of ETST, stated in a news release. An article … Continue reading “NetworkNewsBreaks – Earth Science Tech, Inc. (ETST) Secures Laboratory Partner for Clinical Studies of MSN-2 Medical Device”

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 212.418.1217